Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning: A Novel Regimen Inducing Immunosuppression Without Myelosuppression
暂无分享，去创建一个
E. Jabbour | F. Turturro | U. Popat | Wei Wei | A. Alousi | R. Champlin | R. Bassett | P. Anderlini | C. Hosing | B. Oran | S. Ciurea | M. Korbling | A. Gulbis | R. Valverde | Saira S. Ahmed | Maria Guillermo-Pacheco